Modulation of apolipoprotein C-III expression

Details for Australian Patent Application No. 2004231550 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Lemonidis Tarbet, Kristina M.; Crooke, Rosanne M.; Graham, Mark J.; Dobie, Kenneth W.

Agent Davies Collison Cave

Pub. Number AU-B-2004231550

PCT Pub. Number WO2004/093783

Priority 10/418,780 16.04.03 US

Filing date 15 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 29 October 2009

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

10 November 2005 PCT application entered the National Phase

  PCT publication WO2004/093783 Priority application(s): WO2004/093783

29 October 2009 Application Accepted

  Published as AU-B-2004231550

25 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004231552-Process of forming corn flaking grits of improved quality with minimization of production of corn doubles

2004231547-Dough made with encapsulated soda